Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer

Zhang L, Teng PC, Cavassani KA, Wang J, Grasso C, Watson J, Chen Z, Tu KH, Salumbides B, Rohena-Rivera K, Gevorkian L, Kim M, You S, Di Vizio D, Sandler HM, Daskivich T, Bhowmick NA, Freeman MR, Tseng HR, Chen JF, Posadas EM. Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer. Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-3660. Epub ahead of print. PMID: 40063516.


Related Posts